(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 0.57%3.53B | 2.42%12.8B | 8.31%9.47B | 12.06%6.98B | 13.93%3.51B | 5.32%12.5B | 3.53%8.75B | -5.03%6.23B | -8.51%3.08B | 26.64%11.87B |
Operating income | 0.57%3.53B | 2.42%12.8B | 8.31%9.47B | 12.06%6.98B | 13.93%3.51B | 5.32%12.5B | 3.53%8.75B | -5.03%6.23B | -8.51%3.08B | 26.64%11.87B |
Operating expenses | -5.45%-1.74B | -18.70%-5.26B | -14.11%-1.65B | -0.84%-4.43B | -10.49%-1.45B | |||||
Gross profit | -3.79%1.78B | -2.35%4.22B | 13.77%1.85B | 6.45%4.32B | -20.68%1.63B | |||||
Selling expenses | 0.22%-1.49M | ---- | -45.40%-5.64M | ---- | -76.69%-1.49M | ---- | -1,515.35%-3.88M | ---- | -7,225.59%-845.34K | ---- |
Administrative expenses | 0.54%-23.84M | ---- | 79.34%-90.55M | ---- | -7.60%-23.97M | ---- | -452.53%-438.25M | ---- | -1.83%-22.28M | ---- |
Research and development expenses | 92.46%-387.92K | ---- | -11.74%-13.82M | ---- | -23.35%-5.15M | ---- | -12.59%-12.36M | ---- | -13.01%-4.17M | ---- |
Profit from asset sales | ---21.7K | ---- | 309.86%714.01K | ---- | ---- | ---- | -95.34%174.21K | ---- | ---- | ---- |
Employee expense | ---- | -14.42%-1.25B | ---- | -7.28%-463.01M | ---- | -5.90%-1.09B | ---- | -10.34%-431.57M | ---- | -34.21%-1.03B |
Depreciation and amortization | ---- | -5.94%-5.3B | ---- | -13.95%-2.71B | ---- | -12.33%-5B | ---- | -10.67%-2.37B | ---- | -15.93%-4.45B |
Impairment and provision | ---- | ---- | 117.93%37.18M | ---- | ---- | ---- | -134.02%-207.39M | ---- | ---13.6M | ---- |
-Other impairment is provision | ---- | ---- | 117.93%37.18M | ---- | ---- | ---- | -134.02%-207.39M | ---- | ---13.6M | ---- |
Special items of operating profit | 5.72%99.97M | -372.00%-950.37M | 9.42%244.37M | -286.99%-240.74M | 3.33%94.56M | 87.49%-201.35M | 123.74%223.34M | 113.72%128.74M | -4.33%91.51M | -91.00%-1.61B |
Adjustment items of operating profit | ---- | ---- | -117.93%-74.36M | ---- | ---- | ---- | --414.79M | ---- | ---- | ---- |
Operating profit | -3.75%1.81B | -14.50%5.31B | 0.21%4.23B | 0.52%3.57B | 13.79%1.88B | 29.94%6.21B | 18.71%4.22B | 15.18%3.55B | -20.99%1.66B | 21.79%4.78B |
Financing income | ---- | 5.62%30.83M | ---- | -19.44%11.8M | ---- | 30.02%29.19M | ---- | 11.70%14.64M | ---- | -39.65%22.45M |
Financing cost | 4.93%-407.63M | 11.18%-1.72B | 13.66%-1.29B | 16.25%-877.43M | 17.51%-428.76M | 8.59%-1.94B | 4.63%-1.49B | -3.74%-1.05B | -4.27%-519.77M | 0.70%-2.12B |
Share of profits of associates | ---- | -81.71%8.62M | ---- | 12.30%27.16M | ---- | 602.12%47.14M | ---- | 29.82%24.19M | ---- | -116.49%-9.39M |
Special items of earning before tax | 5.90%3.87M | ---- | -92.44%12.06M | ---- | -34.22%3.65M | ---- | 719.87%159.5M | ---- | 1,172.98%5.56M | ---- |
Earning before tax | -3.38%1.41B | -16.58%3.62B | 2.25%2.95B | 7.44%2.73B | 27.80%1.46B | 62.79%4.34B | 46.97%2.89B | 20.78%2.54B | -28.54%1.14B | 41.97%2.67B |
Tax | -2.72%-201.78M | -17.06%-529.65M | -50.67%-437.11M | -46.58%-378.68M | -49.30%-196.43M | -20.18%-452.47M | 9.15%-290.11M | 17.91%-258.35M | 35.84%-131.56M | -15.17%-376.48M |
After-tax profit from continuing operations | -4.33%1.21B | -20.50%3.09B | -3.16%2.51B | 3.01%2.35B | 25.00%1.26B | 69.79%3.89B | 57.87%2.6B | 27.60%2.28B | -27.47%1.01B | 47.61%2.29B |
Earning after tax | -4.33%1.21B | -20.50%3.09B | -3.16%2.51B | 3.01%2.35B | 25.00%1.26B | 69.79%3.89B | 57.87%2.6B | 27.60%2.28B | -27.47%1.01B | 47.61%2.29B |
Minority profit | 9.26%139.58M | -16.15%340.47M | -1.40%259.5M | 4.91%255.74M | 1.99%127.76M | 56.11%406.06M | -12.88%263.18M | 14.79%243.77M | -30.72%125.27M | -28.88%260.11M |
Profit attributable to shareholders | -5.85%1.07B | -21.00%2.75B | -3.36%2.25B | 2.78%2.09B | 28.25%1.14B | 71.55%3.49B | 73.78%2.33B | 29.32%2.04B | -26.99%885.19M | 71.18%2.03B |
Basic earnings per share | -3.69%0.1306 | -23.54%0.3079 | -7.91%0.2409 | 0.74%0.2447 | 31.78%0.1356 | 93.89%0.4027 | 99.39%0.2616 | 33.46%0.2429 | -29.23%0.1029 | 62.90%0.2077 |
Diluted earnings per share | -3.69%0.1306 | -23.54%0.3079 | -7.91%0.2409 | 0.74%0.2447 | 31.78%0.1356 | 93.89%0.4027 | 99.39%0.2616 | 33.46%0.2429 | -29.23%0.1029 | 62.90%0.2077 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | -- | -- | Ernst & Young (Special General Partnership), Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data